NCT02708732已完成不适用
UK Utility Study in Diffuse Large B-Cell Lymphoma
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 91
- 试验地点
- 1
- 主要终点
- Health-Related Quality of Life According to European Quality of Life 5-Dimension 5-Level (EQ-5D-5L) Score
研究概览
简要总结
This study is a prospective, cross-sectional survey to be administered to real patients in remission from DLBCL using a 15-minute postal or online survey. The project is designed to describe the impact of DLBCL remission on health utility and quality of life. Data collection will occur over a 4-month period.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults greater than or equal to (>/=) 18 years of age
- •Diagnosis of DLBCL and currently in first remission
- •Prior drug treatment for DLBCL
排除标准
- •Receiving active treatment for DLBCL
- •Relapsed following any treatment for DLBCL
结局指标
主要结局
Health-Related Quality of Life According to European Quality of Life 5-Dimension 5-Level (EQ-5D-5L) Score
时间窗: Up to 4 months of data collection
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Real-World Study of DLBCL With Different Genetic SubtypesDLBCL - Diffuse Large B Cell LymphomaLymphomaNCT06026488Ruijin Hospital10,000
Unknown
不适用
Multicenter Prospective Registry Study of Diffuse Large B Cell LymphomaDiffuse Large B Cell LymphomaNeutropenia, FebrileNCT02474550Ajou University School of Medicine1,000
终止
3 期
Study Comparing Zevalin Regimen With no Further Treatment in Patients With Diffuse Large B-cell Lymphoma.Lymphoma, Large Cell, DiffuseNCT00322218Spectrum Pharmaceuticals, Inc68
招募中
不适用
PET Adapted Treatment of Patients With Limited Stage DLBCL and no Risk FactorsLymphoma, Non-Hodgkin's, AdultNCT05078840Grupo Argentino de Tratamiento de la Leucemia Aguda75
已完成
不适用
Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-RituximabLymphoma, Large-Cell, DiffuseNCT00561379Nantes University Hospital350